News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the UBS Global Specialty Pharmaceuticals Conference


CUPERTINO, Calif., April 19 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the UBS Global Specialty Pharmaceuticals Conference. The conference is taking place April 24 - 25th at The Grand Hyatt Hotel in New York City, New York. Schond L. Greenway, Vice President, Investor Relations and Strategic Planning, will be presenting at the conference on Tuesday, April 25th at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Daylight Time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. The company is developing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time to treat chronic and episodic diseases and conditions.

SOURCE DURECT Corporation
04/19/2006
CONTACT: Schond L. Greenway, Vice President, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.durect.com
(DRRX)